Maky Zanganeh
$1.0B
Born
Sep 13, 1970
Age
55
Source of Wealth
Biotech
Residence
Atherton, California
Citizenship
United States
Marital Status
Married
Children
1
Education
Master of Business Administration, Schiller International University; DDS, University of Strasbourg
- Maky Zanganeh is co-CEO of Summit Therapeutics, a biotech firm with a promising drug candidate to treat lung cancer. She owns just under 5% of the company's stock.
- Zanganeh, an immigrant from Iran, previously served as chief operating officer of drug firm Pharmacyclics, which was acquired by AbbVie for $21 million in 2015.
- Zanganeh first came to the U.S. to work for robotic surgery firm Computer Motion in 2002 after running the company's European operations.
- Zanganeh runs Summit Therapeutics as co-CEO with Robert (Bob) Duggan, who became a billionaire after investing in and running Pharmacyclics. She and Duggan married in 2024.
- She trained as a dentist at university in Strasbourg, France and then obtained an MBA while first working at Computer Motion.
- Zanganeh, who attended high school in Germany and university in France, speaks Persian, German, French and English.
- Zanganeh is a cancer survivor; she was diagnosed with breast cancer in 2019 and has since recovered.
| Exchange | Ticker | Company Name | Number Of Shares | Share Price | Currency Code |
|---|